
CAS 1215358-58-9
:Bilastine-d6
CAS:Controlled ProductApplications Labelled Bilastine. It is a novel, nonsedating H1-antihistamine developed for symptomatic treatment of allergic rhinitis and chronic idiopathic urticaria.
References Van Cauwenberge, P., et al.: Clin. Exp. Allergy, 30, 891 (2000), Bauchau, V., et al.: Eur. Respir. J., 24, 758 (2004), Lehman, J., et al.: Drugs, 66, 2309 (2006),Formula:C28H31D6N3O3Color and Shape:White To Light BrownMolecular weight:469.65Bilastine-d6
CAS:Bilastine-d6 is an analog of Bilastine, which is a potent inhibitor of kinases. It has been shown to have anticancer properties and induces apoptosis in tumor cells. Bilastine-d6 inhibits the activity of kinases that are involved in cell division and proliferation, making it a potential candidate for cancer treatment. Studies have also shown that Bilastine-d6 enhances the antitumor effects of artesunate and chloroquine in human cancer cells. This inhibitor can be detected in urine samples, making it suitable for use as a biomarker in cancer diagnosis and monitoring. Its potential as an anticancer agent makes Bilastine-d6 a promising avenue for further research into new cancer treatments.
Formula:C28H31D6N3O3Purity:Min. 95%Color and Shape:PowderMolecular weight:469.65 g/mol


